← Back to Search

Observational (survey, medical chart review) for Brain Tumor

N/A
Waitlist Available
Led By Rebecca A Harrison
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Summary

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Eligible Conditions
  • Brain Tumor
  • Brain Metastasis
  • Leptomeningeal Neoplasm

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")
Secondary outcome measures
Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of care
Incidence of acute care sought (through emergency room or urgent care clinic)
Interactive time spent during visit
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Observational (survey, medical chart review)Experimental Treatment2 Interventions
Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,039 Previous Clinical Trials
1,799,501 Total Patients Enrolled
Rebecca A HarrisonPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
100 Total Patients Enrolled
Barbara J O'Brien, MDPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
17 Total Patients Enrolled
~40 spots leftby Sep 2025